Literature DB >> 15712196

High incidence of malformation syndromes in a series of 1,073 children with cancer.

Johannes Hans M Merks1, Huib N Caron, Raoul C M Hennekam.   

Abstract

Constitutional molecular defects are known to play a role in oncogenesis, as shown by the increased incidence of embryonic cancers in children with Beckwith-Wiedemann syndrome (BWS) or of leukemia in children with Down syndrome. To establish the incidence and spectrum of malformation syndromes associated with childhood cancer we performed a clinical morphological examination on a series of 1,073 children with cancer. We diagnosed a syndrome in 42 patients (3.9%) and suspected the presence of a syndrome in another 35 patients (3.3%), for a total of 7.2%. This incidence of patients with a proven or suspected syndrome is high, and points to a possible association. We describe new syndrome-tumor associations in several entities: cleidocranial dysostosis (Wilms tumor), Bardet-Biedl syndrome (BBS) (acute lymphoblastic leukemia), Kabuki syndrome (neuroblastoma), LEOPARD syndrome (neuroblastoma), Poland anomaly (osteosarcoma; Hodgkin disease), and blepharophimosis epicanthus inversus syndrome (Burkitt lymphoma). Twenty of the 42 syndrome diagnoses were not recognized in the patients prior to this study, indicating that these diagnoses are commonly missed. We propose that all children with a malignancy should be examined by a clinical geneticist or a pediatrician skilled in clinical morphology to determine if the patients have a malformation syndrome. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15712196     DOI: 10.1002/ajmg.a.30603

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

1.  Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Authors:  Hiroyuki Kato; Kaori Asamitsu; Wendi Sun; Shojiro Kitajima; Naoko Yoshizawa-Sugata; Takashi Okamoto; Hisao Masai; Lorenz Poellinger
Journal:  Oncogene       Date:  2020-02-18       Impact factor: 9.867

Review 2.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

Review 3.  Epigenetics and B-cell lymphoma.

Authors:  Rita Shaknovich; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

4.  Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability.

Authors:  Xia Liu; Hong Zheng; Cheng-Kui Qu
Journal:  Cancer Res       Date:  2012-08-13       Impact factor: 12.701

5.  The utilization of counseling skills by the laboratory genetic counselor.

Authors:  McKinsey L Goodenberger; Brittany C Thomas; Karen E Wain
Journal:  J Genet Couns       Date:  2014-08-20       Impact factor: 2.537

6.  The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients.

Authors:  Saskia M J Hopman; Johannes H M Merks; Corianne A J M de Borgie; Cora M Aalfs; Leslie G Biesecker; Trevor Cole; Charis Eng; Eric Legius; Eamonn R Maher; Max M van Noesel; Alain Verloes; David H Viskochil; Anja Wagner; Rosanna Weksberg; Huib N Caron; Raoul C M Hennekam
Journal:  Eur J Cancer       Date:  2013-07-12       Impact factor: 9.162

Review 7.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

8.  Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE).

Authors:  Caroline Munzer; Florence Menegaux; Brigitte Lacour; Dominique Valteau-Couanet; Jean Michon; Carole Coze; Christophe Bergeron; Anne Auvrignon; Frédéric Bernard; Caroline Thomas; Jean-Pierre Vannier; Justyna Kanold; Hervé Rubie; Denis Hémon; Jacqueline Clavel
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

9.  Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.

Authors:  Chong Kun Cheon; Young Bae Sohn; Jung Min Ko; Yeoun Joo Lee; Ji Sun Song; Jea Woo Moon; Bo Kyoung Yang; Il Soo Ha; Eun Jung Bae; Hyun-Seok Jin; Seon-Yong Jeong
Journal:  J Hum Genet       Date:  2014-04-17       Impact factor: 3.172

10.  Paediatric germ cell tumours and congenital abnormalities: a Children's Oncology Group study.

Authors:  K J Johnson; J A Ross; J N Poynter; A M Linabery; L L Robison; X O Shu
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.